Three Part Question
In [patients with chest pain and an ischaemic ECG] does [a negative troponin T/I result] rule out [the occurrence of adverse cardiac events in the ensuing month].
Clinical Scenario
A 62-year-old man presents to the emergency department with a 45-minute history of chest pain that is beginning to abate after aspirin and buccal nitrates in the ambulance. As he has a 1 mm ST depression in his anterior leads you give him low molecular-weight heparin and refer him to the medical team. While waiting to be transferred to the ward his 12-h troponin level is reported as negative; the medical senior house officer feels he is therefore fit for discharge. You disagree saying he remains high risk and needs further investigation and/or intervention. During the ensuing discussion you wonder if there is any evidence to back up your assertions
Search Strategy
Medline 1966 to January Week 2 2009 using the OVID interface:
[{exp TROPONIN C/OR exp TROPONIN T/OR exp TROPONIN/OR exp TROPONIN I/OR troponin.af} AND {exp DEATH/OR exp DEATH, SUDDEN, CARDIAC/OR exp PROGNOSIS/OR exp MORTALITY/OR exp Myocardial Infarction/OR death.af. OR mortality.af. OR prognos$.af. OR predict$.af. OR myocardial infarction.af. OR heart attack.af.} AND {("30" adj5 day).af. OR (thirty adj5 day).af. OR (one adj5 month).af. OR ("1" adj5 month).af.} AND {exp Electrocardiography/OR electrocardiogr$.af. OR ECG.af OR EKG.af}] LIMIT to human and English Language.
The Cochrane Library Issue 1 2009: [MeSH descriptor Chest Pain explode all trees] AND [MeSH descriptor Troponin explode all trees] AND [MeSH descriptor Prognosis explode all trees] 35 records 0 relevant.
Search Outcome
A total of 71 papers was found, of which three answered the three-part question.
Relevant Paper(s)
Author, date and country |
Patient group |
Study type (level of evidence) |
Outcomes |
Key results |
Study Weaknesses |
Ohman ME et al. 1996 USA/Canada/Germany | 855 patients with chest pain and abnormal ecgs as part of the GUSTO IIa study | Prospective diagnostic study | Adjusted relative value as predictors of 30 day mortality by CHI squared at 3DF | Trop T 9.2 ECG 11.5 | Most trop T < 12 hours post pain. Patients divided into various treatments as substudy of PCRT on mortality prevention. Trop T cut off of 0.1 used. Large proprtion of patients with STEMI. |
Wilcox G et al 2001 Melbourne | 424 patients presenting to the ED with chest pain. | Prospective diagnostic study | Odds ratio on multivariate analysis (95% CI) | Trop I 0.6-2.0microg/l 2.2 (0.7-6.8) Ischamic ECG 1.3 (0.5-3.6) | Timing of trop I measurement not stated.
Small numbers. |
Alp et al 2001 UK | 400 patients>30 yoa in CCU with chest pain | Prospective diagnostic | Death at 30 days | Tn I +ve 4%.(1-13%) Tn I-ve ECG ischaemic 2% (0-9%) | 45/51 TnI +ve patients had ischaemic ECG. Small numbers. Trop I measured at 6 hours |
MI at 30 days | Tn I +ve 63% (48-75%) Tn I-ve ECG ischaemic 9% (3-19%) |
Comment(s)
All the studies above have flaws in particular in the timing of troponin measurement. However all point to troponin rises and ischamic changes being independent predictors of mortality/MI in the next 30 days.
Clinical Bottom Line
Negative troponin does not make an ischaemic ECG low risk chest pain, however a combination of the two points to a very high risk group.
References
- Ohman EM. Armstrong PW. Christenson RH. Granger CB. Katus HA. Hamm CW. O'Hanesian MA. Wagner GS. Kleiman NS. Harrell FE Jr. Califf RM. Topol EJ. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. New England Journal of Medicine. 335(18):1333-41, 1996 Oct 31
- Wilcox G. Archer PD. Bailey M. Dziukas L. Lim CF. Schneider HG Measurement of cardiac troponin I levels in the emergency department: predictive value for cardiac and all-cause mortality Medical Journal of Australia. 174(4):170-3, 2001 Feb 19.
- Alp NJ. Bell JA. Shahi M. A rapid troponin-I-based protocol for assessing acute chest pain QJM. 94(12):687-94, 2001 Dec.